Kolon TissueGene Competitors and Similar CompaniesClear all

Kolon TissueGene's competitors and similar companies include OXGENE, ZIOPHARM Oncology, EpiDisease and Novocodex Biopharmaceuticals.

	Kolon TissueGene Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders.	OXGENE OXGENE (also known as Oxford Genetics) is a synthetic biology company.	ZIOPHARM Oncology ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer.	EpiDisease Epidisease is an epigenetics company.	Novocodex Biopharmaceuticals Novocodex Biopharmaceuticals (版权所有浙江新码生物医药有限公司) is a company engaged in the research and development of biological products.
Founding Date	Founding Date 1999	Founding Date 2011	Founding Date 2005	Founding Date 2014	Founding Date 2017
Type	Type Private	Type Subsidiary	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma	Tags Healthcare biotech genetics pharma
Locations	Locations Rockville, US HQ	Locations Oxford, GB HQ	Locations Boston, US HQ	Locations ES HQ Paterna, ES	Locations Shaoxing Shi, CN HQ
Employees	Employees 615% increase	Employees 264% increase	Employees 7352% increase	Employees 15	Employees 34
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £1m (FY, 2018)	Revenue (est.) $5k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income (£2.7m) (FY, 2018)	Net income ($4.2m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 125.1m	Total funding raised $ 344k	Total funding raised $ 62m